Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today.
Rines kicks off by debunking the common myth that HIPAA compliance ensures full safety in targeted marketing, shedding light on the complexities of state laws and the risks companies face if they fall behind.
He also dives into the transformative role of AI in shaping future ad strategies for both physicians and patients, forecasting how personalized and predictive targeting will soon be the norm.
Rines further reflects on Swoop’s recent transition to an independent company and what this means for its focus on AI-driven innovation and strategic acquisitions. He explores how the company’s cutting-edge HCP Pro Suite is redefining traditional targeting, creating deeper connections between physicians and patients by leveraging a variety of data points to ensure meaningful, personalized engagement.
Tune in for a compelling conversation on the future of pharma marketing, privacy in healthcare data, and the power of AI to revolutionize patient care. Don’t miss this insightful interview!
{Categories} _Category: Takes{/Categories}
{URL}https://www.fiercepharma.com/sponsored/future-pharma-marketing-ai-privacy-and-personalization{/URL}
{Author}cbroadwell{/Author}
{Image}https://qtxasset.com/quartz/qcloud5/public/brightcove/videos/images/posters/image_1492.jpg?VersionId=3KaRuwwwpf8ZaoE_i0tvc7gZdK8eaREe{/Image}
{Keywords}{/Keywords}
{Source}POV{/Source}
{Thumb}{/Thumb}